RU2008148290A - BICYCLIC DERIVATIVES AS CETR INHIBITORS - Google Patents
BICYCLIC DERIVATIVES AS CETR INHIBITORS Download PDFInfo
- Publication number
- RU2008148290A RU2008148290A RU2008148290/04A RU2008148290A RU2008148290A RU 2008148290 A RU2008148290 A RU 2008148290A RU 2008148290/04 A RU2008148290/04 A RU 2008148290/04A RU 2008148290 A RU2008148290 A RU 2008148290A RU 2008148290 A RU2008148290 A RU 2008148290A
- Authority
- RU
- Russia
- Prior art keywords
- alkyl
- unsubstituted
- substituted
- cycloalkyl
- alkoxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Abstract
1. Соединение формулы (I) !! в которой кольцо A, которое аннелировано с кольцом В, представляет собой незамещенный или замещенный карбоциклический ароматический радикал или незамещенный или замещенный гетероциклический ароматический радикал; в которой Ar представляет собой незамещенный или замещенный карбоциклический ароматический радикал; ! R1 обозначает элемент -C(=O)-R3, -C(-O)-O-R3, -C(=O)-NR4R5, -S(O)m-R3, -S(O)m-N(R4)(R5), m в каждом случае является целым числом, равным 0, 1 или 2, или R1 обозначает Z, ! Z выбран из группы, включающей (i) незамещенный или замещенный моноциклический циклоалкил или незамещенный или замещенный моноциклический циклоалкенил, (ii) незамещенный или замещенный карбоциклический ароматический радикал или незамещенный или замещенный гетероциклический радикал; ! R2 выбран из группы, включающей -C(=O)-R3, -C(-O)-O-R3, -N(R4)(R5) и -S(O)m-N(R4)(R5) и -NR3-S(O)m-N(R4)(R5), m в каждом случае является целым числом, равным 0, 1 или 2; ! R3 независимо обозначает водород, алкил, галогеналкил, незамещенный или замещенный циклоалкил, незамещенный или замещенный циклоалкенил, в циклоалкильном фрагменте незамещенный или замещенный циклоалкилалкил, в циклоалкенильном фрагменте незамещенный или замещенный циклоалкенилалкил, незамещенный или замещенный карбоциклический ароматический радикал, незамещенный или замещенный гетероциклический радикал или в арильном фрагменте незамещенный или замещенный арилалкил; ! R4 и R5 независимо друг от друга обозначают водород, алкил, или циклоалкил, указанный алкил содержит один или большее количество заместителей, выбранных из группы, включающей незамещенный или замещенный циклоалкил, незамещенный или замещенный циклоалкен� 1. The compound of formula (I) !! in which ring A, which is annelated with ring B, is an unsubstituted or substituted carbocyclic aromatic radical or an unsubstituted or substituted heterocyclic aromatic radical; in which Ar is an unsubstituted or substituted carbocyclic aromatic radical; ! R1 is the element -C (= O) -R3, -C (-O) -O-R3, -C (= O) -NR4R5, -S (O) m-R3, -S (O) mN (R4) (R5), m in each case is an integer equal to 0, 1 or 2, or R1 is Z,! Z is selected from the group consisting of (i) unsubstituted or substituted monocyclic cycloalkyl or unsubstituted or substituted monocyclic cycloalkenyl, (ii) unsubstituted or substituted carbocyclic aromatic radical or unsubstituted or substituted heterocyclic radical; ! R2 is selected from the group consisting of -C (= O) -R3, -C (-O) -O-R3, -N (R4) (R5) and -S (O) mN (R4) (R5) and -NR3 -S (O) mN (R4) (R5), m in each case is an integer equal to 0, 1 or 2; ! R3 independently represents hydrogen, alkyl, haloalkyl, unsubstituted or substituted cycloalkyl, unsubstituted or substituted cycloalkenyl, in the cycloalkyl fragment, unsubstituted or substituted cycloalkylalkyl, in the cycloalkenyl fragment, unsubstituted or substituted cycloalkenylalkyl or unsubstituted substituted carbocyclic aromatic or a fragment of unsubstituted or substituted arylalkyl; ! R4 and R5 are independently hydrogen, alkyl, or cycloalkyl; said alkyl contains one or more substituents selected from the group consisting of unsubstituted or substituted cycloalkyl, unsubstituted or substituted cycloalkene
Claims (14)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0609268.8A GB0609268D0 (en) | 2006-05-10 | 2006-05-10 | Organic compounds |
GB0609268.8 | 2006-05-10 | ||
US86648006P | 2006-11-20 | 2006-11-20 | |
US60/866,480 | 2006-11-20 | ||
US60/896,142 | 2007-03-21 |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2008148290A true RU2008148290A (en) | 2010-06-20 |
RU2430917C2 RU2430917C2 (en) | 2011-10-10 |
Family
ID=36637241
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2008148290/04A RU2430917C2 (en) | 2006-05-10 | 2007-05-08 | Bicyclic derivatives as cept inhibitors |
Country Status (6)
Country | Link |
---|---|
JP (1) | JP4926241B2 (en) |
CN (1) | CN101622242B (en) |
BR (1) | BRPI0711384A2 (en) |
GB (1) | GB0609268D0 (en) |
PE (1) | PE20080066A1 (en) |
RU (1) | RU2430917C2 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4846769B2 (en) * | 2007-07-30 | 2011-12-28 | 田辺三菱製薬株式会社 | Pharmaceutical composition |
JPWO2014017569A1 (en) * | 2012-07-26 | 2016-07-11 | 興和株式会社 | Medicine for lowering blood LDL |
EP2919765A2 (en) * | 2012-11-19 | 2015-09-23 | Dr. Reddy's Laboratories Ltd. | Pharmaceutical compositions of cetp inhibitors |
CN103351354B (en) * | 2013-06-09 | 2015-08-12 | 西安近代化学研究所 | 1-methyl-5-amino tetrazole synthetic method |
CN103524445A (en) * | 2013-09-09 | 2014-01-22 | 南通市华峰化工有限责任公司 | Method for synthetic production of 1-methyl-5-aminotetrazole |
CN107304174B (en) * | 2016-04-21 | 2019-05-10 | 沈阳药科大学 | Disubstituted cycloalkenyl methylamine like derivative of N, N- and its preparation method and application |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003221376A (en) * | 2001-11-21 | 2003-08-05 | Japan Tobacco Inc | Cept activity inhibitor |
BR0306208A (en) * | 2002-08-30 | 2004-10-13 | Japan Tobacco Inc | Dibenzylamine compounds and their pharmaceutical use |
DK1848430T3 (en) * | 2004-12-31 | 2017-11-06 | Dr Reddys Laboratories Ltd | NEW BENZYLAMINE DERIVATIVES AS CETP INHIBITORS |
WO2007075194A1 (en) * | 2005-12-28 | 2007-07-05 | Reddy Us Therapeutics, Inc. | Selective benzylamine derivatives and their utility as cholesterol ester-transfer protein inhibitors |
UY30118A1 (en) * | 2006-01-31 | 2007-06-29 | Tanabe Seiyaku Co | AMIS TRISUSTITUDE COMPUTER |
-
2006
- 2006-05-10 GB GBGB0609268.8A patent/GB0609268D0/en not_active Ceased
-
2007
- 2007-05-08 CN CN2007800205902A patent/CN101622242B/en not_active Expired - Fee Related
- 2007-05-08 JP JP2009508242A patent/JP4926241B2/en not_active Expired - Fee Related
- 2007-05-08 PE PE2007000555A patent/PE20080066A1/en not_active Application Discontinuation
- 2007-05-08 BR BRPI0711384-6A patent/BRPI0711384A2/en not_active IP Right Cessation
- 2007-05-08 RU RU2008148290/04A patent/RU2430917C2/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
BRPI0711384A2 (en) | 2011-11-22 |
GB0609268D0 (en) | 2006-06-21 |
JP2009536172A (en) | 2009-10-08 |
CN101622242B (en) | 2013-07-17 |
RU2430917C2 (en) | 2011-10-10 |
JP4926241B2 (en) | 2012-05-09 |
PE20080066A1 (en) | 2008-03-17 |
CN101622242A (en) | 2010-01-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2008148290A (en) | BICYCLIC DERIVATIVES AS CETR INHIBITORS | |
JP5089377B2 (en) | Immunosuppressant and antitumor agent containing heterocyclic compound as active ingredient | |
US8211911B2 (en) | Compounds as kinase inhibitors | |
TWI543961B (en) | Novel hydroxamic acid derivatives | |
EA019768B1 (en) | Compounds modulating activity of toll-like receptors | |
EP2655340A1 (en) | Bi-heteroaryl compounds as vps34 inhibitors | |
KR20080089499A (en) | Novel lactams | |
EA018150B1 (en) | 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use | |
JP2015528440A (en) | N2, N4-bis (4- (piperazin-1-yl) phenyl) pyrimidine-2,4-diamine derivative or a pharmaceutically acceptable salt thereof, and cancer containing this derivative or salt as an active ingredient Composition for treating | |
KR20090043506A (en) | Compounds with a potentiating effect on ethionamide activity, and uses thereof | |
NO20060650L (en) | Quinazoline derivatives as angiogenesis inhibitors | |
RU2008130922A (en) | Pyridinylamine derivatives as protein-carrier inhibitors of cholesterol esters | |
US20230088095A1 (en) | Methods of treating elevated plasma cholesterol | |
RU2744168C1 (en) | New pyrimidine derivative with an effect of inhibiting growth of cancer cells and pharmaceutical composition containing it | |
KR20150074186A (en) | Heteroaryl alkyne compound and application thereof | |
JP2001048786A (en) | Tricyclic heteroaryl derivative | |
EP2917185A1 (en) | Sulfoximine substituted quinazolines for pharmaceutical compositions | |
CA2968874A1 (en) | Small molecule inhibitors of fibrosis | |
WO2010030967A1 (en) | 4-aryloxyquinolin-2(1h)-ones as mtor kinase and pi3 kinase inhibitors, for use as anti-cancer agents | |
NO20060641L (en) | Quinazoline derivatives as inhibitors of VEGF receptor tyrosine kinases | |
EP3527571A1 (en) | Pyrimidine derivatives for prevention and treatment of bacterial infection | |
EP3312176A1 (en) | Antimicrobial 4-oxoquinolizines | |
CA2742743A1 (en) | Pharmaceutical combinations comprising a pyrido [4,3-d] pyrimidine derived hsp90-inhibitor and a her2 inhibitor | |
JP2012512246A5 (en) | ||
CA3226950A1 (en) | Fused ring heteroaryl compounds and use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20140509 |